Mark Pruzanski - Sep 30, 2021 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC. (ICPT)

Role
Director
Signature
/s/ Mary J. Grendell, as attorney-in-fact
Stock symbol
ICPT
Transactions as of
Sep 30, 2021
Transactions value $
$34,452
Form type
4
Date filed
10/4/2021, 05:02 PM
Previous filing
Sep 1, 2021
Next filing
Nov 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Award $91.1K +6.14K +1% $14.85 618K Sep 30, 2021 Direct F1
transaction ICPT Common Stock Tax liability -$56.7K -3.82K -0.62% $14.85 614K Sep 30, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock delivered in respect of performance stock unit awards previously granted to the reporting person; such delivery being made pursuant to the Retirement and Consulting Agreement by and between the Issuer and the reporting person, dated December 9, 2020.
F2 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit and performance stock unit awards previously granted to the reporting person.